Trials / Terminated
TerminatedNCT00740272
Af Ablation In Brady-Tachy Syndrome
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 38 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to evaluate the impact of atrial fibrillation ablation in patients presenting a brady-tachy syndrome on the AF burden. The hypothesis of the study is that AF ablation prevents not only from AF episodes recurrence but also from bradycardic episodes.
Detailed description
The study is a randomized study 1:1 AF ablation vs non AF ablation. Patients are followed for 1 year. 38 patients will be required to show a significant reduction in AF burden.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | AF ablation + pacemaker implantation | regular pacemaker implantation and concomitant AF ablation procedure (PV isolation) |
| PROCEDURE | Pacemaker implantation | regular pacemaker implantation |
Timeline
- Start date
- 2008-03-01
- Primary completion
- 2009-12-01
- Completion
- 2009-12-01
- First posted
- 2008-08-22
- Last updated
- 2019-02-04
Locations
3 sites across 1 country: France
Source: ClinicalTrials.gov record NCT00740272. Inclusion in this directory is not an endorsement.